Physician profile
Raj Patel
NPI 1467947341
$4,988.05
in general payments reported to CMS, 2019-2025
8 companies · $48.08 in 2025
The $48.08 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.57 · 2021: $122 · 2023: $4,488 · 2024: $268 · 2025: $48.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,344 · Food and Beverage: $1,324 · Education: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,344.37 |
| Food and Beverage | $1,324.24 |
| Education | $135.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,964.81 | 2023-2024 | Ensite Precision, Ensite, Assurity |
| Medtronic, INC. | $1,510.53 | 2023-2025 | Advisa Dr Mri Surescan, Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $242.37 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $76.71 | 2024 | |
| Sanofi-Aventis U.S. LLC | $66.36 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $65.70 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.66 | 2019 | |
| Pfizer INC. | $15.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raj Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.